Researchers want to test the effectiveness of a new pain medication. Four hundred people were recruited to participate in the clinical trial. In clinical testing, 40 out of 201 people taking the medication reported pain symptoms. Of the other 199 people receiving a placebo, 20 reported pain symptoms. Combining the two samples together, what is the overall proportion of those who reported pain symptoms among all participants?
0.15
0.47
0.19
0.34
Researchers want to test the effectiveness of a new pain medication. Four hundred people were recruited...
Researchers want to test the effectiveness of a new anti-anxiety medication. Three hundred eighty patients were recruited to participate in the clinical trial. In clinical testing, 73 out of 200 people taking the medication reported symptoms of anxiety. Of the other 180 people receiving a placebo, 86 reported symptoms of anxiety. Combining the two samples together, what is the overall proportion of those who reported symptoms of anxiety among all participants? 0.37 0.42 0.33 0.29
Researchers are interested in the effectiveness of a new allergy medication; they want to know whether the medication will reduce the severity of allergy symptoms. Researchers also want to know which method of delivery is best pill, skin patch, or nasal mist). They collect a volunteer sample of 120 adults (aged 20 - 50) who are experiencing allergy symptoms. They randomly assign 60 adults to the placebo and 60 adults to the active drug. From each group of 60 they...
A drug company wanted to test the effectiveness of a new pain reliever for people who suffer from migraine headaches. They selected a random sample of 400 people who suffer from migraine headaches and gave 200 of them the new pain reliever; the other 200 were given a placebo (i.e., a sugar pill that appeared in all respects identical to the new pain reliever). After one month, people in both groups were asked to report if the pill they took...
Clinical trial The design of the clinical trial for this study represented a single centered, double blind, placebo-controlled trial that utilized randomization to target patients for the trial. The eligible patients for the study were aged 21-90 years and after receiving a biopsy, these patients had confirmed colorectal adenocarcinoma and were deemed eligible for receiving treatment for the surgery to remove their adenocarcinoma, but were instead given an opportunity to participate in this research trial with written informed consent. Potential...